Diseases [C] » Stomatognathic Diseases [C07] » Mouth Diseases » Periodontal Diseases » Periodontitis
Description
Inflammation and loss of connective tissues supporting or surrounding the teeth. This may involve any part of the PERIODONTIUM. Periodontitis is currently classified by disease progression (CHRONIC PERIODONTITIS; AGGRESSIVE PERIODONTITIS) instead of age of onset. (From 1999 International Workshop for a Classification of Periodontal Diseases and Conditions, American Academy of Periodontology) MeSH
Hierarchy View
Subtype Terms (5)
Aggressive Periodontitis
12 drugs (10 approved, 2 experimental)
Chronic Periodontitis
87 drugs (38 approved, 49 experimental)
Periapical Periodontitis
19 drugs (11 approved, 8 experimental)
Periodontal Pocket
24 drugs (12 approved, 12 experimental)
Approved Indicated Drugs (1)
Phase 4 Indicated Drugs (36)
Phase 3 Indicated Drugs (8)
Phase 2 Indicated Drugs (18)
Phase 1 Indicated Drugs (5)
Other Experimental Indicated Drugs (40)
Organization Involved with Phase 4 Indications (60)
Centro Superior de Investigación en Salud Publica
Chemische Fabrik Kreussler & CO GmbH
Chhattisgarh Dental College and Research Institute
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Dr. August Wolff GmbH & Co. KG Arzneimittel
Dr. D. Y. Patil Dental College & Hospital
Federal University of Maranhao
Federal University of Minas Gerais
Fundação de Amparo à Pesquisa do Estado de São Paulo
Ho Chi Minh City University of Medicine and Pharmacy
Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre
Rajiv Gandhi University of Health Sciences
Riyadh Colleges of Dentistry and Pharmacy
Sri Hasanamba Dental College and Hospital
Tatyasaheb Kore Dental College
Organization Involved with Phase 3 Indications (34)
Centro Universitario de Tonalá
Dexcel Pharma Technologies Ltd.
Dow University of Health Sciences
Government Dental College and Hospital, Vijayawada, Andhra Pradesh
Government Dental College and Research Institute, Bangalore
Government Dental College & Hospital, Aurangabad
Instituto Venezolano de Investigaciones Cientificas
Islamic Azad University of Tabriz
KLE Society's Institute of Dental Sciences
Organization Involved with Phase 2 Indications (47)
Aristotle University of Thessaloniki
Belarusian Medical Academy of Post-Graduate Education
Belarusian Research Center for Pediatric Oncology, Hematology and Immunology
Belarusian State Medical University
Bill and Melinda Gates Foundation
Carol Davila University of Medicine and Pharmacy
Govt Dental College & Research Inst, Bangalore.
Himalaya Drug Company Ltd. India
National Academy of Sciences of Belarus
National Center for Complementary and Integrative Health (NCCIH)
National Center for Research Resources (NCRR)
Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences
People's Liberation Army of China
Organization Involved with Phase 1 Indications (8)
Organization Involved with Other Experimental Indications (43)
Bareilly International University
Centro Universitario de Lavras
Dr. Peter C. Fritz, Periodontal Wellness & Implant Surgery
Government College of Dentistry, Indore
Immunology Research Institute in Gifu
Instituto de Medicina Integral Professor Fernando Figueira
Meenakshi Ammal Dental College and Hospital
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
